Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Report Store
UsernamePublicRestriction
Tags:
OTC Drugs

FDA Lifts Curtain On The Secret Behind Magic Power Coffee

This article was originally published in The Tan Sheet

  • News
  • The Tan Sheet

Executive Summary

FDA's consumer advisory against a coffee product that contains an active drug ingredient for erectile dysfunction reflects the agency's growing capability to keep up with noncompliant firms that add drug substances to so-called dietary supplements
Table

View full table

Advertisement

Related Content

HBW Insight
Coffee Product Percolates On FDA's Spiked Supplement Import Radar
Pink Sheet
Tainted Supplement Warnings Stress FDA’s Enforcement Limitations
Pink Sheet
Tainted Supplement Warnings Stress FDA’s Enforcement Limitations
Pink Sheet
FDA finds drugs in EZVille supplements
Pink Sheet
Magic Power Coffee reveals a recall
Pink Sheet
FDA Should Not Judge A Liquid Supplement By Its Packaging - Stakeholders
Pink Sheet
Sharfstein Says Spiked Products Top FDA Supplement Enforcement Goals
Pink Sheet
AHPA Says H1N1 Enforcement Tactics Would Work To Find Hidden Steroids
Pink Sheet
FDA Action On Sexual Supplements Should Spur Better Self-Policing – UNPA
Pink Sheet
FDA Action On Sexual Supplements Should Spur Better Self-Policing – UNPA

Topics

Advertisement
Tags:
OTC Drugs
UsernamePublicRestriction

Register

PS104247

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By